Vincenzo Pitini

Messina, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

STAT6 activation correlates with cerebrospinal fluid IL-4 and IL-10 and poor prognosis in primary central nervous system lymphoma.

STAT6 activation correlates with cerebrospinal fluid IL-4 and IL-10 and poor prognosis in primary central nervous system lymphoma.

Journal: Hematological oncology

Published: May 22, 2019

Interferon Alpha Has a Strong Anti-tumor Effect in Philadelphia-negative Myeloproliferative Neoplasms.

Interferon Alpha Has a Strong Anti-tumor Effect in Philadelphia-negative Myeloproliferative Neoplasms.

Journal: Clinical lymphoma, myeloma & leukemia

Published: January 21, 2019

Thyroid hormone autoantibodies: are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments?

Thyroid hormone autoantibodies: are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments?

Journal: Current oncology (Toronto, Ont.)

Published: June 23, 2016

Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?

Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?

Journal: The oncologist

Published: March 12, 2016

Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent.

Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent.

Journal: Experimental hematology & oncology

Published: October 29, 2015

Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin's lymphoma: evidence from a multicenter, retrospective study.

Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin's lymphoma: evidence from a multicenter, retrospective study.

Journal: Annals of hematology

Published: October 24, 2015

90Y-Ibritumomab-Tiuxetan Consolidation Therapy for Advanced-Stage Mantle Cell Lymphoma After First-Line Autologous Stem Cell Transplantation: Is It Time for a Step Forward?

90Y-Ibritumomab-Tiuxetan Consolidation Therapy for Advanced-Stage Mantle Cell Lymphoma After First-Line Autologous Stem Cell Transplantation: Is It Time for a Step Forward?

Journal: Clinical lymphoma, myeloma & leukemia

Published: July 31, 2015

Personalized treatment of early-stage non-small-cell lung cancer: the challenging role of EGFR inhibitors.

Personalized treatment of early-stage non-small-cell lung cancer: the challenging role of EGFR inhibitors.

Journal: Future oncology (London, England)

Published: April 03, 2015

Is radiotherapy still necessary for diffuse large B-cell lymphoma therapy?

Is radiotherapy still necessary for diffuse large B-cell lymphoma therapy?

Journal: Acta oncologica (Stockholm, Sweden)

Published: April 02, 2015

Should the use of surveillance imaging in diffuse large B-cell lymphoma be discontinued?

Should the use of surveillance imaging in diffuse large B-cell lymphoma be discontinued?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 25, 2015

Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments.

Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments.

Journal: Leukemia research

Published: March 10, 2015

Thyroid function, autoimmunity and nodules in hematological malignancies.

Thyroid function, autoimmunity and nodules in hematological malignancies.

Journal: Archives of endocrinology and metabolism

Published: January 01, 2015

Showing 1-12 of 27

Last Updated: 09/26/2026